• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG.大肠杆菌尿嘧啶DNA糖基化酶(EcUDG)与一种蛋白质抑制剂复合物的X射线分析。一种原核尿嘧啶DNA糖基化酶的结构解析。
Nucleic Acids Res. 1998 Nov 1;26(21):4880-7. doi: 10.1093/nar/26.21.4880.
2
Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase.来自尿嘧啶-DNA糖基化酶抑制剂蛋白及其与大肠杆菌尿嘧啶-DNA糖基化酶复合物晶体结构的DNA蛋白质模拟
J Mol Biol. 1999 Mar 26;287(2):331-46. doi: 10.1006/jmbi.1999.2605.
3
Complexes of the uracil-DNA glycosylase inhibitor protein, Ugi, with Mycobacterium smegmatis and Mycobacterium tuberculosis uracil-DNA glycosylases.尿嘧啶-DNA糖基化酶抑制剂蛋白Ugi与耻垢分枝杆菌和结核分枝杆菌尿嘧啶-DNA糖基化酶的复合物。
Microbiology (Reading). 2003 Jul;149(Pt 7):1647-1658. doi: 10.1099/mic.0.26228-0.
4
The role of leucine 191 of Escherichia coli uracil DNA glycosylase in the formation of a highly stable complex with the substrate mimic, ugi, and in uracil excision from the synthetic substrates.大肠杆菌尿嘧啶DNA糖基化酶中亮氨酸191在与底物类似物ugi形成高度稳定复合物以及从合成底物中切除尿嘧啶过程中的作用。
J Biol Chem. 2001 May 18;276(20):17324-31. doi: 10.1074/jbc.M011166200. Epub 2001 Feb 8.
5
Crystal structure of Escherichia coli uracil DNA glycosylase and its complexes with uracil and glycerol: structure and glycosylase mechanism revisited.大肠杆菌尿嘧啶DNA糖基化酶及其与尿嘧啶和甘油复合物的晶体结构:对结构和糖基化酶作用机制的重新审视
Proteins. 1999 Apr 1;35(1):13-24.
6
Cloning and expression of the uracil-DNA glycosylase inhibitor (UGI) from bacteriophage PBS-1 and crystallization of a uracil-DNA glycosylase-UGI complex.噬菌体PBS-1尿嘧啶-DNA糖基化酶抑制剂(UGI)的克隆、表达及尿嘧啶-DNA糖基化酶-UGI复合物的结晶
Proteins. 1995 Jul;22(3):287-9. doi: 10.1002/prot.340220310.
7
Mutational analysis of the uracil DNA glycosylase inhibitor protein and its interaction with Escherichia coli uracil DNA glycosylase.尿嘧啶DNA糖基化酶抑制剂蛋白的突变分析及其与大肠杆菌尿嘧啶DNA糖基化酶的相互作用。
J Mol Biol. 2002 Aug 23;321(4):579-90. doi: 10.1016/s0022-2836(02)00654-x.
8
Domain closure and action of uracil DNA glycosylase (UDG): structures of new crystal forms containing the Escherichia coli enzyme and a comparative study of the known structures involving UDG.尿嘧啶DNA糖基化酶(UDG)的结构域封闭与作用:包含大肠杆菌该酶的新晶体形式的结构以及涉及UDG的已知结构的比较研究
Acta Crystallogr D Biol Crystallogr. 2002 Aug;58(Pt 8):1269-76. doi: 10.1107/s0907444902009599. Epub 2002 Jul 20.
9
Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA.人尿嘧啶-DNA糖基化酶与一种蛋白质抑制剂复合物的晶体结构:DNA的蛋白质模拟
Cell. 1995 Sep 8;82(5):701-8. doi: 10.1016/0092-8674(95)90467-0.
10
Substitutions at tyrosine 66 of Escherichia coli uracil DNA glycosylase lead to characterization of an efficient enzyme that is recalcitrant to product inhibition.大肠杆菌尿嘧啶DNA糖基化酶第66位酪氨酸的替换导致一种高效酶的特性得以表征,该酶对产物抑制具有抗性。
Nucleic Acids Res. 2003 Dec 15;31(24):7216-26. doi: 10.1093/nar/gkg918.

引用本文的文献

1
Uracil DNA glycosylase (UDG) activities in Bradyrhizobium diazoefficiens: characterization of a new class of UDG with broad substrate specificity.慢生根瘤菌中尿嘧啶DNA糖基化酶(UDG)活性:一类具有广泛底物特异性的新型UDG的特性分析
Nucleic Acids Res. 2017 Jun 2;45(10):5863-5876. doi: 10.1093/nar/gkx209.
2
Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.同源瞬时蛋白质-蛋白质复合物界面中结构特征的弱保守性。
Protein Sci. 2015 Nov;24(11):1856-73. doi: 10.1002/pro.2792. Epub 2015 Sep 8.
3
A unique uracil-DNA binding protein of the uracil DNA glycosylase superfamily.尿嘧啶DNA糖基化酶超家族中一种独特的尿嘧啶-DNA结合蛋白。
Nucleic Acids Res. 2015 Sep 30;43(17):8452-63. doi: 10.1093/nar/gkv854. Epub 2015 Aug 24.
4
Structural and biophysical analysis of interactions between cod and human uracil-DNA N-glycosylase (UNG) and UNG inhibitor (Ugi).鳕鱼与人类尿嘧啶-DNA N-糖基化酶(UNG)及UNG抑制剂(Ugi)之间相互作用的结构与生物物理分析。
Acta Crystallogr D Biol Crystallogr. 2014 Aug;70(Pt 8):2093-100. doi: 10.1107/S1399004714011699. Epub 2014 Jul 25.
5
Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage Φ29 DNA mimic protein p56.噬菌体 Φ29 DNA 模拟蛋白 p56 对尿嘧啶-DNA 糖基化酶的抑制作用的晶体结构和功能见解。
Nucleic Acids Res. 2013 Jul;41(13):6761-73. doi: 10.1093/nar/gkt395. Epub 2013 May 13.
6
Purification, crystallization and preliminary X-ray analysis of uracil-DNA glycosylase from Sulfolobus tokodaii strain 7.嗜热栖热放线菌7株尿嘧啶-DNA糖基化酶的纯化、结晶及初步X射线分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Sep 1;68(Pt 9):1102-5. doi: 10.1107/S1744309112030278. Epub 2012 Aug 31.
7
Novel dimeric structure of phage φ29-encoded protein p56: insights into uracil-DNA glycosylase inhibition.噬菌体 φ29 编码蛋白 p56 的新型二聚体结构:对尿嘧啶-DNA 糖基化酶抑制作用的深入了解。
Nucleic Acids Res. 2011 Dec;39(22):9779-88. doi: 10.1093/nar/gkr667. Epub 2011 Sep 2.
8
Structure of uracil-DNA glycosylase from Mycobacterium tuberculosis: insights into interactions with ligands.结核分枝杆菌尿嘧啶-DNA糖基化酶的结构:对与配体相互作用的见解
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Aug 1;66(Pt 8):887-92. doi: 10.1107/S1744309110023043. Epub 2010 Jul 27.
9
Structure of uracil-DNA N-glycosylase (UNG) from Vibrio cholerae: mapping temperature adaptation through structural and mutational analysis.霍乱弧菌尿嘧啶-DNA糖基化酶(UNG)的结构:通过结构和突变分析绘制温度适应性图谱。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Feb 1;66(Pt 2):130-6. doi: 10.1107/S1744309109052063. Epub 2010 Jan 26.
10
Analysis of the impact of a uracil DNA glycosylase attenuated in AP-DNA binding in maintenance of the genomic integrity in Escherichia coli.分析尿嘧啶 DNA 糖基化酶在结合 AP-DNA 方面的减弱对大肠杆菌基因组完整性维持的影响。
Nucleic Acids Res. 2010 Apr;38(7):2291-301. doi: 10.1093/nar/gkp1210. Epub 2010 Jan 7.

大肠杆菌尿嘧啶DNA糖基化酶(EcUDG)与一种蛋白质抑制剂复合物的X射线分析。一种原核尿嘧啶DNA糖基化酶的结构解析。

X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG.

作者信息

Ravishankar R, Bidya Sagar M, Roy S, Purnapatre K, Handa P, Varshney U, Vijayan M

机构信息

Molecular Biophysics Unit and Department of Microbiology and Cell Biology, Indian Institute of Science,Bangalore 560 012, India.

出版信息

Nucleic Acids Res. 1998 Nov 1;26(21):4880-7. doi: 10.1093/nar/26.21.4880.

DOI:10.1093/nar/26.21.4880
PMID:9776748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC147935/
Abstract

Uracil-DNA glycosylase (UDG), a key highly conserved DNA repair enzyme involved in uracil excision repair, was discovered in Escherichia coli . The Bacillus subtilis bacteriophage, PBS-1 and PBS-2, which contain dUMP residues in their DNA, express a UDG inhibitor protein, Ugi which binds to UDG very tightly to form a physiologically irreversible complex. The X-ray analysis of the E. coli UDG ( Ec UDG)-Ugi complex at 3.2 A resolution, leads to the first structure elucidation of a bacterial UDG molecule. This structure is similar to the enzymes from human and viral sources. A comparison of the available structures involving UDG permits the delineation of the constant and the variable regions of the molecule. Structural comparison and mutational analysis also indicate that the mode of action of the enzyme from these sources are the same. The crystal structure shows a remarkable spatial conservation of the active site residues involved in DNA binding in spite of significant differences in the structure of the enzyme-inhibitor complex, in comparison with those from the mammalian and viral sources. Ec UDG could serve as a prototype for UDGs from pathogenic prokaryotes, and provide a framework for possible drug development against such pathogens with emphasis on features of the molecule that differ from those in the human enzyme.

摘要

尿嘧啶-DNA糖基化酶(UDG)是参与尿嘧啶切除修复的一种关键的高度保守的DNA修复酶,它最初是在大肠杆菌中发现的。枯草芽孢杆菌噬菌体PBS-1和PBS-2的DNA中含有dUMP残基,它们表达一种UDG抑制蛋白Ugi,该蛋白与UDG紧密结合形成生理上不可逆的复合物。以3.2埃的分辨率对大肠杆菌UDG(Ec UDG)-Ugi复合物进行X射线分析,首次阐明了细菌UDG分子的结构。该结构与来自人类和病毒源的酶相似。对涉及UDG的现有结构进行比较,可以勾勒出该分子的恒定区和可变区。结构比较和突变分析还表明,这些来源的酶的作用模式是相同的。晶体结构显示,尽管与哺乳动物和病毒源的酶-抑制剂复合物结构存在显著差异,但参与DNA结合的活性位点残基在空间上具有显著的保守性。Ec UDG可以作为致病原核生物UDG的原型,并为针对此类病原体的药物开发提供框架,重点关注该分子与人类酶不同的特征。